Inhibition of the PI3K signaling pathway by BKM120 inhibited tumor growth and lung metastasis by enhancing anti-tumor immunity by decreasing the number of CD4+ TILs, increasing the number of activated CD4+CD69+ T cells, and decreasing the number of CD20+ B cells. This evidence concerns the gene CD4 and neoplasm.